INTRODUCTION
Determining significant metabolic changes in Dementia with Lewy Bodies (DLB), a complex and multifactorial neurodegenerative disease, requires, in addition to the analysis of concentration changes, a deep understanding of functional modifications in the context of metabolic networks.
METHODS
Brain metabolomics data from DLB patients and controls was explored using novel correlation analysis approaches to identify metabolites with the largest changes in their network in the disease state.
RESULTS
Novel clustering and correlation network analysis shows major change in the metabolic network in DLB brain relative to matching controls with the largest interaction network alterations for fructose, propylene-glycol, pantothenate and O-acetylcarnitine in spite of no statistically significant changes in their concentrations.
DISCUSSION
Network and correlation analyses indicate major changes in the purine degradation pathway, propanoate and b-alanine metabolism as well as an increased role of fructose and reduced significance of glucose in DLB affected brain.